Johannes H Schulte Selected Research

Nerve Growth Factor Receptors (Neurotrophin Receptors)

11/2014	Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells.
5/2009	The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo.
10/2008	Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.
12/2005	The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness.
1/2005	Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johannes H Schulte Research Topics

Disease

83	Neuroblastoma 04/2022 - 01/2005
76	Neoplasms (Cancer) 01/2022 - 01/2005
9	Medulloblastoma 02/2020 - 01/2011
6	Retinoblastoma (Glioblastoma, Retinal) 04/2021 - 09/2012
6	Carcinogenesis 10/2019 - 02/2009
4	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2013
3	Disease Progression 01/2021 - 10/2015
2	Hemorrhage 01/2022 - 10/2020
2	Rhabdomyosarcoma 12/2021 - 02/2020
2	Infections 08/2021 - 01/2011
2	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021 - 01/2019
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 01/2020
2	Carcinoma (Carcinomatosis) 10/2019 - 11/2011
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018 - 11/2016
2	Brain Neoplasms (Brain Tumor) 04/2017 - 01/2011
1	Hemophilia B (Haemophilia B) 01/2022
1	Hemophilia A (Haemophilia) 01/2022
1	Granuloma 01/2022
1	Fibrosarcoma 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2021
1	Adenoviridae Infections (Adenovirus Infections) 08/2021
1	Uveal melanoma 04/2021
1	Astrocytoma (Pilocytic Astrocytoma) 04/2021
1	Primitive Neuroectodermal Tumors (PNET) 04/2021
1	Meningioma (Meningiomas) 04/2021
1	Superinfection 01/2021
1	Hyperemia 01/2021
1	Fever (Fevers) 01/2021
1	Pain (Aches) 01/2021

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2008
20	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2008
15	Messenger RNA (mRNA)IBA 01/2021 - 11/2005
11	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2008
9	Biological ProductsIBA 06/2021 - 01/2005
7	Anaplastic Lymphoma KinaseIBA 12/2021 - 09/2010
7	Biomarkers (Surrogate Marker)IBA 07/2020 - 11/2010
6	Transcription Factors (Transcription Factor)IBA 01/2020 - 11/2008
6	Small Interfering RNA (siRNA)IBA 05/2016 - 11/2008
5	Chimeric Antigen ReceptorsIBA 10/2021 - 09/2019
5	AntigensIBA 10/2021 - 09/2019
5	Pharmaceutical PreparationsIBA 07/2020 - 07/2013
5	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 11/2014 - 01/2005
4	Histone DemethylasesIBA 10/2021 - 03/2009
4	RNA (Ribonucleic Acid)IBA 10/2021 - 02/2013
4	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 01/2017
4	Phosphotransferases (Kinase)IBA 02/2020 - 10/2014
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2014 - 01/2005
3	Cell-Free Nucleic AcidsIBA 04/2022 - 11/2020
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2021 - 01/2015
3	NucleotidesIBA 07/2021 - 01/2020
3	Polo-Like Kinase 1IBA 04/2017 - 02/2011
3	EnzymesIBA 04/2017 - 03/2009
3	Lysine (L-Lysine)FDA Link 09/2013 - 03/2009
2	Peptides (Polypeptides)IBA 06/2021 - 01/2013
2	Retinaldehyde (Retinal)IBA 04/2021 - 09/2012
2	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 03/2021 - 01/2021
2	dinutuximabIBA 01/2021 - 01/2021
2	ProteomeIBA 01/2021 - 08/2014
2	CytokinesIBA 01/2021 - 01/2020
2	Circular DNAIBA 04/2020 - 01/2020
2	GSK 461364IBA 04/2017 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 04/2017 - 01/2017
2	BI 2536IBA 01/2017 - 02/2011
2	ChromatinIBA 01/2016 - 03/2009
2	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2015 - 07/2015
2	Differentiation AntigensIBA 11/2014 - 11/2008
2	Conditioned Culture MediaIBA 11/2014 - 08/2013
2	trkA ReceptorIBA 11/2014 - 08/2013
2	Histones (Histone)IBA 05/2013 - 03/2009
2	Adrenergic Agents (Adrenergic Drugs)IBA 11/2012 - 05/2009
2	Oncogene Proteins (Oncogene Protein)IBA 07/2012 - 07/2012
2	LigandsIBA 01/2011 - 01/2005
2	trkB ReceptorIBA 10/2008 - 10/2005
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2022
1	Rubella VaccineIBA 01/2022
1	ceritinibIBA 12/2021
1	brincidofovirIBA 08/2021
1	Acyclovir (Aciclovir)FDA LinkGeneric 08/2021
1	NucleoproteinsIBA 06/2021
1	Semaphorin-3AIBA 06/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Dipyrone (Metamizole)IBA 01/2021
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2021

Therapy/Procedure

31	Therapeutics 01/2022 - 01/2009
9	Drug Therapy (Chemotherapy) 01/2022 - 01/2012
6	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2019
4	Transplantation 01/2021 - 01/2012
3	Combined Modality Therapy 01/2017 - 10/2015
2	Stem Cell Transplantation 01/2022 - 01/2021
2	Investigational Therapies (Experimental Therapy) 01/2017 - 01/2017
1	Contraindications 08/2021
1	Lasers (Laser) 06/2021
1	Analgesia 01/2021
1	Fluid Therapy (Oral Rehydration Therapy) 01/2021